Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile
NCT01226407
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumour
Interventions
DRUG:
CG200745
Sponsor
CrystalGenomics, Inc.